Company Profile

Home
Markets
Company Profile

No Details Found

Overview
Key Ratios
Financials
Shareholding
Company Info
Peer Comparison

Morepen Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

Morepen
BSE Code : 2685.0
ISIN : INE083A01026

53.20 -4 (-6.37%)

As on 23 Jul 2026 (EOD)

Today’s Low
52.90
Today’s High
56.85

Open
56.80
Perv Close
56.82
52W Low
33.05
52W High
64.58

Key Indicators

P/E(TTM)

44.76
Mar.Cap (₹Cr.)

2,915.11
Div & Yield %

0.38
Book Value(₹)

22.68
Debt-Equity Ratio

-6.37
AGM Date

22-Jul-2026
EPS

1.19
P/E Ratio

44.76

Financials Ratios

Debt-Equity Ratio

0.03
Mar.Cap (₹Cr.)

2,915.11

RONW (%)

12.08
ROCE (%)

16.12

Score Board

Equity (₹ in Cr.)

109.59
BV (₹)

22.70
Sales( ₹ in Cr.)

1,681.20
NP (in Cr.)

65.25
NP Var(%)

-36.0
Div%

10.0
CPS (₹)

1.70
EPS (₹)

1.20
Traded Value (₹ in Lakhs)

2,918.95

52 Week High

64.58
52 Week Low

33.05
Price BSE

53.0
Price NSE

53.00
Market Capital( in Cr.)

2,918.95
P/C Ratio

30.70
P/E Ratio

44.50
Price Vs.BV

1.20

01-Jul-2026( 09:09)

Corporate News - Morep... - <P>Morepen Laboratories t...
27-May-2026( 11:06)

Corporate News - Board... - Morepen Laboratories announced...
27-May-2026( 07:35)

Results - Announcements - Morep... - Net profit of Morepen Laborato...
22-May-2026( 12:35)

Corporate News - Morep... - Morepen Laboratories has revis...

Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)

Particulars(INCOME)	2025 Mar	2024 Mar	2023 Mar	2022 Mar	2021 Mar	2020 Mar
INCOME :
Sales Turnover	1,554.54	1,537.59	1,338.88	1,449.27	1,112.42	791.99
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1,554.54	1,537.59	1,338.88	1,449.27	1,112.42	791.99
Other Income	15.72	12.57	5.76	10.24	11.77	9.42
Stock Adjustments	44.36	-5.13	-16.54	-1.74	41.98	7.58
Total Income	1,614.62	1,545.03	1,328.10	1,457.77	1,166.17	808.99
EXPENDITURE :
Raw Materials	1,019.99	945.15	886.48	988.81	778.60	528.67
Power and Fuel Cost	40.62	34.09	23.78	18.93	13.00	12.56
Employee Cost	177.22	160.28	146.19	150.00	123.20	98.07
Other Manufacturing Expenses	52.15	44.19	33.81	23.39	13.57	10.54
Selling and Administration Expenses	134.27	163.47	111.62	87.90	82.36	73.37
Miscellaneous Expenses	21.23	23.47	43.19	49.36	31.30	11.89
Employee Benefit Expenses	177.22	160.28	146.19	150.00	123.20	98.07
Less: Preoperative Expenditure	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenses	1,445.48	1,370.64	1,245.08	1,318.39	1,042.03	735.10
Operating Profit	169.13	174.39	83.03	139.37	124.15	73.89
Interest	7.10	3.51	1.98	-7.37	1.79	1.97
Gross Profit	162.03	170.88	81.05	146.74	122.36	71.92
Depreciation	24.44	21.90	18.01	21.19	28.11	34.43
Profit Before Tax	137.59	148.98	63.04	125.55	94.25	37.49
Current Tax	31.28	38.48	16.60	22.00	0.00	5.15
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	4.73	-0.44	0.20	2.48	0.00	0.00
Reported Net Profit	101.58	110.94	46.24	101.06	94.25	32.33
Extraordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Net Profit	101.58	110.94	46.24	101.06	94.25	32.33
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	328.20	217.27	171.03	74.96	-19.29	-51.62
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	5.00	0.00	0.00
P & L Balance carried down	429.78	328.20	217.27	171.03	74.96	-19.29
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend (%)	10.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.20	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	1.85	2.17	0.90	2.12	2.10	0.72
Earnings Per Share(Adj)-Unit Curr	1.85	2.17	0.90	2.12	2.10	0.72
Book Value	21.56	17.39	15.26	11.97	8.92	6.83
Book Value(Adj)-Unit Curr	21.56	17.39	15.26	11.97	8.92	6.83

Shareholding Pattern

Promoter Group

35.65%
Public Share Holding

64.35%

Category of Shareholder	No of Shares	% Holdings	Demat Shares	Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate	0	0.00	0	0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign)	0	0.00	0	0
Foreign Promoter(Institutional)	0	0.00	0	0
Promoter Others	0	0.00	0	0
Sub Total	0	0.00	0	0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group)	154,129,838	28.13	154,129,838	11
Government(Central / State)-Indian (Promoter & Group)	0	0.00	0	0
Directors & their Relatives-Indian (Promoter & Group)	0	0.00	0	0
Financial Institutions / Banks-Indian (Promoter & Group)	0	0.00	0	0
Individuals / Hindu Undivided Family-Indian (Promoter & Group)	41,241,750	7.53	41,241,750	24
Partnership Firms-Indian (Promoter & Group)	0	0.00	0	0
Persons Acting in Concert	0	0.00	0	0
Trusts	0	0.00	0	0
Others	0	0.00	0	0
Sub Total	195,371,588	35.65	195,371,588	35
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State)	60,000	0.01	60,000	1
Clearing Members	0	0.00	0	0
Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
Financial Institutions / Banks	1,706,657	0.31	1,706,657	2
Foreign Bank	0	0.00	0	0
Foreign Bodies Corporate/OCBs/FBC	0	0.00	0	0
Foreign Collaborators	0	0.00	0	0
Foreign Institutional Investors	8,002,750	1.46	8,002,750	38
Foreign Venture Capital Investors	0	0.00	0	0
Foreign Institution Other	0	0.00	0	0
Insurance Companies	5,143,530	0.94	5,143,530	4
Mutual Funds / UTI	15,225	0.00	15,225	2
Individuals (Non-Resident / Foreign)	0	0.00	0	0
NSDL Intransit	0	0.00	0	0
Others	163,380	0.03	163,380	2
Trusts	0	0.00	0	0
Venture Capital Funds	0	0.00	0	0
Sub total	15,091,542	2.75	15,091,542	49
2] Non Institution
Bodies Corporate	11,996,633	2.19	11,363,262	730
Clearing Members	1,675,109	0.31	1,675,109	64
Directors of their Relatives	0	0.00	0	0
Employees	0	0.00	0	0
Escrow Account	0	0.00	0	0
Foreign Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
NRIs/Foreign Individuals/Foreign Nationals	6,706,795	1.22	6,705,138	3,332
Foreign Non Institution Other	38,893,097	7.10	38,893,097	4
Hindu Undivided Families	0	0.00	0	0
Indian Public	0	0.00	0	0
Individuals holding nominal share capital in excess of Rs. 1 lakh	31,735,536	5.79	26,917,641	99
Individuals holding nominal share capital up to Rs. 1 lakh	240,877,424	43.96	220,472,296	430,592
Market Maker	0	0.00	0	0
NSDL Transit	0	0.00	0	0
Shares in transit	0	0.00	0	0
Societies	0	0.00	0	0
Trust & Foundation	28,831	0.01	28,831	6
Others	0	0.00	0	0
Sub Total	337,490,569	61.59	311,632,518	434,828
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR	0	0.00	0	0
GDR	0	0.00	0	0
Other Custodians	0	0.00	0	0
Total Shares held by Custodians and against which Depository Receipts have been issued	0	0.00	0	0
Grand Total ( A + B + C )	547,953,699	100.00	522,095,648	434,912

Company Background

Morepen Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

Morepen Laboratories Ltd
BSE Code : 2685.0
ISIN : INE083A01026

Incorporation Year

1984
Registered Office

Morepen Village
Nalagarh Road Near Baddi, Solan,
Himachal Pradesh-173205
Telephone

91-01795-276201-03
FAX

91-01795-276204
Chairman

Sushil Suri
Managing Director
Company Secretary

Vipul Kumar Srivastava
Auditor

S P Babuta & Associates
Face Value

2
Listing

NSE
Registrar

Mas Services Limited
T-34 2nd Floor,
Okhla Industrial Are,Phase II
Mumbai - New Delhi - 110020

Morepen Laboratories Ltd Peer Comparison

Profit & Loss

Financial Ratios

Balance Sheet

Company Name	LTP (₹)	Revenue	Sales	P/E Ratio	ROCE %
Morepen Labs.	53.27	1,570.25	1,554.54	44.02	12.79
P & G Health Ltd	6,718.20	944.52	934.17	34.11	71.75
Sanofi India	3,403.50	1,857.10	1,837.40	25.30	54.17
Glaxosmi. Pharma	2,551.10	3,932.76	3,790.20	42.71	58.17
J B Chemicals &	2,412.25	3,945.17	3,889.89	57.46	24.24
Novartis India	1,699.05	398.23	356.27	45.02	16.64
Cipla	1,415.10	20,102.60	18,979.95	32.52	13.88
Amrutanjan Healt	529.35	469.50	451.82	26.43	21.89
Bliss GVS Pharma	448.15	773.53	729.81	49.09	12.51
Guj. Themis Bio.	351.75	152.47	150.80	82.18	27.21
Ambalal Sarabhai	31.49	19.52	3.94	22.02	6.77